摘要:
The present invention discloses the use of a lycopene coated with a water non-soluble thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5%. The invention further discloses a process for the preparation of stable lycopene formulation comprising (a) treating an isolated protein to form a protein in a molecular form; (b) dispersing lycopene in an aqueous solution comprising an isolated protein in a molecular form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 μm forming an homogenized mixture comprising fine particles; and optionally (d) drying the homogenized mixture.
摘要:
The present invention discloses the use of a lycopene coated with a water non-soluble thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5%. The invention further discloses a process for the preparation of stable lycopene formulation comprising (a) treating an isolated protein to form a protein in a molecular form; (b) dispersing lycopene in an aqueous solution comprising an isolated protein in a molecular form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 μm forming an homogenized mixture comprising fine particles; and optionally (d) drying the homogenized mixture.
摘要:
The present invention discloses the use of a lycopene coated with a water non-soluble thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5%. The invention further discloses a process for the preparation of stable lycopene formulation comprising: (a) treating an isolated protein to form a protein in a molecular form; (b) dispersing lycopene in an aqueous solution comprising an isolated protein in a molecular form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 μm forming an homogenized mixture comprising line particles; and optionally (d) drying the homogenized mixture.
摘要:
Tomatoes are separated into desirable food products by subjecting them, after conventional preliminary treatments, such as crushing, to a separation of serum from pulp by centrifugation at temperatures between 75.degree. and 110.degree. C. and centrifugal force between 2600 and 4000 G, whereby to obtain a pulp that contains at least 500 ppm of lycopene. The pulp is then subjected to extraction by means of solvents having .delta.H (delta H) and .delta.P (delta P) values chosen so as to extract an oleoresin that has a desired content of lycopene, phospholipids and mono- and di-glycerides. The serum is concentrated and mixed either with dehydrated spent tomato pulp or with dispersing agents and the mixture is dried to produce a new food product which is substantially free from sugars and agrochemicals, is low in lipids, and has a water content less than 5 ww %.
摘要:
Provided are homogeneous liquid systems substantially 1H-NMR inactive and/or devoid of protons and are capable of enhancing the diffusion separation of a mixture, the system is substantially devoid of at least one NMR active nucleus present in the mixture. Further provided are methods of using the homogeneous liquid systems for enhancing the diffusion separation of a mixture and/or generating a diffusion ordered spectrum of a mixture and/or minimizing the peak width in a liquid state diffusion ordered spectrum of a mixture.
摘要:
The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.
摘要:
The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.
摘要:
Reverse hexagonal mesophase (HII) liquid crystals provide multi-component hexagonal systems for use in solubilizing and/or protecting from degradation one or more bio-macromolecule and/or active material, and relates to therapeutic and non-therapeutic applications, such as an oral delivery system, where the mesophase is adapted for oral administration. The present invention provides the formation of mesophase systems of ternary glycerol monooleate (GMO)/water combinations which comprise at least one triglyceride or an equivalent thereof. At least one biomacromolecule or drug is incorporated in the mesophase of a pharmaceutical composition or oral delivery system.
摘要:
The present invention is directed to a 3-dimensional optical memory comprising as an active medium a compound capable of interconverting from one isomeric form to another by interaction of light. Said compound is bound to a polymer for achieving a uniform memory unit.
摘要:
The present invention relates to a method for the production of particles of nano-materials being transition metals and alloys; metal oxides; and ceramic compositions having a small nanosize, i.e. about 1-6 nm. The method comprises a synthesis in the solutions of complex liquids from suitable precursors, which precursors are selected from suitable surfactants and alkoxides, by a suitable chemical reaction under mild conditions; and preparing from said materials fine colloids dispersed in various polymer solutions. The water in the solution is preferably non freezing water, the mild conditions are atmospheric pressure and a temperature range of room temperature to 70° C., and the reaction condition is selected among a hydrolysis, reduction and exchange process.